These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17534364)

  • 1. 'Unleashed' natural killers hinder HIV.
    Altfeld M; Goulder P
    Nat Genet; 2007 Jun; 39(6):708-10. PubMed ID: 17534364
    [No Abstract]   [Full Text] [Related]  

  • 2. Host genetics and HIV--removing the mask.
    Michael NL
    Nat Med; 2002 Aug; 8(8):783-5. PubMed ID: 12152029
    [No Abstract]   [Full Text] [Related]  

  • 3. Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses.
    Gaudieri S; Nolan D; McKinnon E; Witt CS; Mallal S; Christiansen FT
    Mol Immunol; 2005 Feb; 42(4):557-60. PubMed ID: 15607813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1.
    Martin MP; Qi Y; Gao X; Yamada E; Martin JN; Pereyra F; Colombo S; Brown EE; Shupert WL; Phair J; Goedert JJ; Buchbinder S; Kirk GD; Telenti A; Connors M; O'Brien SJ; Walker BD; Parham P; Deeks SG; McVicar DW; Carrington M
    Nat Genet; 2007 Jun; 39(6):733-40. PubMed ID: 17496894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population.
    López-Vázquez A; Miña-Blanco A; Martínez-Borra J; Njobvu PD; Suárez-Alvarez B; Blanco-Gelaz MA; González S; Rodrigo L; López-Larrea C
    Hum Immunol; 2005 Mar; 66(3):285-9. PubMed ID: 15784466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy or independence? Deciphering the interaction of HLA Class I and NK cell KIR alleles in early HIV-1 disease progression.
    Barbour JD; Sriram U; Caillier SJ; Levy JA; Hecht FM; Oksenberg JR
    PLoS Pathog; 2007 Apr; 3(4):e43. PubMed ID: 17447840
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression.
    Grifoni A; Montesano C; Palma P; Salerno A; Colizzi V; Amicosante M
    Mol Immunol; 2013 Apr; 53(4):410-3. PubMed ID: 23103378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIR/HLA pleiotropism: protection against both HIV and opportunistic infections.
    Qi Y; Martin MP; Gao X; Jacobson L; Goedert JJ; Buchbinder S; Kirk GD; O'Brien SJ; Trowsdale J; Carrington M
    PLoS Pathog; 2006 Aug; 2(8):e79. PubMed ID: 16933987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Carrying certain KIR3DL1 alleles with HLA-B*57 is associated with protection from HIV infection].
    Boulet S; Bernard NF
    Med Sci (Paris); 2008 Dec; 24(12):1030-2. PubMed ID: 19116110
    [No Abstract]   [Full Text] [Related]  

  • 10. HLA-B molecules target more conserved regions of the HIV-1 proteome.
    Fontaine Costa AI; Rao X; Lechenadec E; van Baarle D; Keşmir C
    AIDS; 2010 Jan; 24(2):211-5. PubMed ID: 19904197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural Killer cells from long-term non-progressor HIV patients are characterized by altered phenotype and function.
    O'Connor GM; Holmes A; Mulcahy F; Gardiner CM
    Clin Immunol; 2007 Sep; 124(3):277-83. PubMed ID: 17611161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of natural killer cell receptors in HIV infected individuals.
    Jiang YJ; Zhang ZN; Diao YY; Geng WQ; Dai D; Liu J; Wang YN; Zhang M; Han XX; Shang H
    Chin Med J (Engl); 2007 Sep; 120(17):1544-8. PubMed ID: 17908466
    [No Abstract]   [Full Text] [Related]  

  • 13. Association of killer immunoglobulin-like receptors and their HLA Class I ligands with progression of chronic hepatitis C virus infection.
    López-Vázquez A; Rodrigo L; López-Larrea C
    Tissue Antigens; 2007 Apr; 69 Suppl 1():241-2. PubMed ID: 17445210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics. First-class control of HIV-1.
    McMichael AJ; Jones EY
    Science; 2010 Dec; 330(6010):1488-90. PubMed ID: 21148380
    [No Abstract]   [Full Text] [Related]  

  • 16. NKG2C is a major triggering receptor involved in the V[delta]1 T cell-mediated cytotoxicity against HIV-infected CD4 T cells.
    Fausther-Bovendo H; Wauquier N; Cherfils-Vicini J; Cremer I; Debré P; Vieillard V
    AIDS; 2008 Jan; 22(2):217-26. PubMed ID: 18097224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KIR-HLA intercourse in HIV disease.
    Carrington M; Martin MP; van Bergen J
    Trends Microbiol; 2008 Dec; 16(12):620-7. PubMed ID: 18976921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NK cells in human disease: an evolving story.
    Guerini FR; Clerici M
    Clin Immunol; 2012 Jun; 143(3):203-6. PubMed ID: 22525888
    [No Abstract]   [Full Text] [Related]  

  • 19. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer.
    Wagtmann N; Rajagopalan S; Winter CC; Peruzzi M; Long EO
    Immunity; 1995 Dec; 3(6):801-9. PubMed ID: 8777725
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunology. The footprint of a killer.
    Kärre K; Schneider G
    Nature; 2000 Jun; 405(6786):527-8. PubMed ID: 10850700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.